Phenylthiocarbamide Taste Perception among HIV- Infected Patients on Highly Active Antiretroviral Therapy
Journal Title: Journal of Advances in Medicine and Medical Research - Year 2017, Vol 19, Issue 10
Abstract
Aim: To determine whether phenylthiocarbamide (PTC) taste perception in HIV infection was influenced by highly active antiretroviral therapy (HAART). Methodology: Study participants were adults (≥16 years) comprising 85 HIV-infected patients on HAART; 83 of whom were on first line of treatment (41 on Lamivudine, Nevirapine and Zidovudine and 42 on Tenofovir, Lamivudine and Efavirenz) and 2 on second line of treatment, 20 asymptomatic HIV-infected persons (and not on any medication) and 100 apparently healthy controls without HIV infection. They were enrolled in this study after clinical examination and informed consent was obtained from each participant. Antibodies to HIV were determined using determine HIV 1/HIV 2 test kit and Enzyme linked immunosorbent assay (ELISA) and then confirmed with Western blot (WB) and Real time PCR. Tasters and non-tasters were determined using phenylthiocarbamide (PTC) taste strips (0.0143 mg/strip). Results: Non-tasters of PTC in the HIV-infected group on HAART (60.0%) were higher than those in the control group (33.0%) (p < 0.001). Non-tasters of PTC among the HIV-infected patients on Tenofovir, Lamivudine and Efavirenz (73.8%) were higher than: (i) Non-tasters of PTC among the HIV-infected patients on Lamivudine, Nevirapine and Zidovudine (46.3%) (p = 0.01) (ii) Non-tasters in the control group (33.0%) (p < 0.001) and (iii) Non-tasters in the asymptomatic HIV-infected group (35.0%) (p = 0.003). Non-tasters of PTC among the HIV-infected patients on Lamivudine, Nevirapine and Zidovudine were not significantly different from non-tasters in the control group (p = 0.13) or those in the asymptomatic HIV-infected group (p = 0.40). Conclusion: This study showed that bitter taste loss of PTC was significantly associated with HIV-infected patients on Tenofovir, Lamivudine and Efavirenz. Therefore, the choice of HAART for HIV infection can influence PTC taste perception.
Authors and Affiliations
C. Igbeneghu, T. B. Oluwatunbi, O. A. Aina, J. M. Olisekodiaka
Keywords
Related Articles
- EP ID EP311043
- DOI 10.9734/BJMMR/2017/29573
- Views 60
- Downloads 0
Assessment of Value of Fatigue Severity and Symptoms in Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and Fibromyalgia
Background and Objective: Chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) remains a challenge for health care professionals because of its complex pathogenesis. Scales and questionnaires have been developed i...
Hyperuricaemia and its Relations with Serum Lipid Abnormalities in Untreated, Newly Diagnosed Adult Nigerian Hypertensive Patients
Aims: To determine the prevalence of hyperuricaemia in adult Nigerians with untreated newly diagnosed hypertension and to evaluate its relations with serum lipid abnormalities. Study Design: Cross-sectional study. Place...
Perception towards Problem Based Learning among Medical Students of a Private Medical College in South India
Introduction: Meeting the changing demands in medical education requires implementation of innovative teaching methods. Problem based learning (PBL) was introduced for the first time for teaching Community Medicine at Ka...
Vitamin D Receptor fok I Gene Polymorphism in Angiographically Proven Coronary Artery Disease Subjects: Case - Control Study
Aims: Coronary artery disease (CAD) is multifactorial disease resulting from modifiable and non modifiable risk factors. Gene polymorphism is one of the non modifiable risk factors, which may contribute to disease suscep...
Profile of Neurocognitive Impairment in Individuals Coinfected with Human Immunodeficiency Virus and Hepatitis C Virus: Meta-analysis and Meta-regression
HIV and HCV are neurotrophic viruses with great potential to cause neurocognitive impairments (NCI). Yet, results of neuro studies among Coinfected individuals are still inconclusive. This study pooled estimates to defin...